Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Baudax Bio Inc (BXRX)

Baudax Bio Inc (BXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Baudax Bio Inc 490 LAPP ROAD MALVERN PA 19355 USA

www.baudaxbio.com P: 484-395-2440

Description:

Baudax Bio Inc. is a pharmaceutical company. It is focused on advancing non-opioid analgesics and other products for the hospital and other acute care settings. The Company's lead product candidate is a proprietary intravenous form of meloxicam, a non-opioid, long-acting preferential COX-2 inhibitor. Baudax Bio Inc. is based in Malvern, Pennsylvania.

Key Statistics

Overview:

Market Capitalization, $K 1,144
Enterprise Value, $K 3,004
Shares Outstanding, K 52,460
Annual Sales, $ 1,270 K
Annual Net Income, $ -58,800 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,980 K
EBIT, $ -22,060 K
EBITDA, $ -19,900 K
60-Month Beta 1.58
% of Insider Shareholders 0.10%
% of Institutional Shareholders 9.05%
Float, K 52,408
% Float 99.90%
Short Volume Ratio 0.00

Growth:

1-Year Return -99.01%
3-Year Return -100.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.29 on 11/20/23
Next Earnings Date 03/07/24
Earnings Per Share ttm -17.30
EPS Growth vs. Prev Qtr 80.54%
EPS Growth vs. Prev Year 99.71%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-40 on 12/01/22

BXRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -175.11%
Profit Margin % -4,629.92%
Debt/Equity -0.51
Price/Sales 0.30
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.84
Interest Coverage -0.30
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar